1 Two electrode voltage clamp and single channel recordings were used to investigate the actions of various ATP-sensitive K + (K ATP ) channel inhibitors on cloned K ATP channels, expressed in Xenopus oocytes and HEK 293 cells. 2 Oocytes expressing Kir6.2 and SUR1 gave rise to inwardly rectifying K + currents following bath application of 3 mM sodium azide. Inside-out recordings from non-azide treated oocytes demonstrated the presence of K ATP channels which were activated by direct application of 3 mM azide and 0.1 mM Mg-ATP. 3 Tolbutamide inhibited azide-induced macroscopic Kir6.2-SUR1 currents, recorded from Xenopus oocytes, with an IC 50 value similar to native K ATP channels. Ciclazindol and englitazone also inhibited these currents in a concentration-dependent manner, but with relative potencies substantially less than for native K ATP channels. 4 Single channel currents recorded from inside-out patches excised from oocytes expressing Kir6.2-SUR1 currents were inhibited by tolbutamide, Mg-ATP, englitazone and ciclazindol, in the absence of azide, with potencies similar to native K ATP channels. In the presence of azide, Kir6.2-SUR1 currents were inhibited by englitazone and tolbutamide but not ciclazindol. 5 Single channel currents derived from Kir6.2D26, expressed in HEK 293 cells, were inhibited by ciclazindol and englitazone irrespective of the absence or presence of SUR1. 6 In conclusion, heterologously expressed Kir6.2 and SUR1 recapitulate the pharmacological pro®le of native pancreatic b-cell K ATP channels. However, currents induced by azide exhibit a substantially reduced sensitivity to ciclazindol. It is likely that ciclazindol and englitazone inhibit K ATP currents by interaction with the Kir6.2 subunit.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.